EFA Magazine

Latest Posts

Abbott Labs pays $1.5 billion to settle Depakote litigation

Abbott Labs on Monday pleaded guilty to marketing the anti-seizure, mood-stabilizing drug Depakote to treat conditions for which it did not have Food and Drug Administration approval, according to news…

News May 8

Technology adoption: Best-of-breed or bust

Business initiatives on the top of executive agendas for today’s long-term care providers are those that emphasize efficiencies, cost control, revenue and care. Technology plays an increasingly important role, accelerating…

Projects May 7

Florida AL operators have few rules for evictions

The assisted living model was designed for seniors and others who need some help with daily activities. It was not intended to provide complex medical care. Many consumers are not…

News May 7
Strategy & Planning Series
Strategy & Planning Series
Strategy & Planning Series
Strategy & Planning Series
Strategy & Planning Series
Strategy & Planning Series